Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
4,507.94
3,780.44
3,245.21
2,325.58
1,919.45
1,513.22
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,507.94
3,780.44
3,245.21
2,325.58
1,919.45
1,513.22
Raw Material Cost
3,102.37
2,680.81
2,264.90
1,590.21
1,289.50
998.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
35.31
31.89
25.40
26.01
8.60
8.19
Selling and Distribution Expenses
1,145.58
920.50
750.52
626.17
506.39
431.81
Other Expenses
-0.71
-0.77
-2.12
-2.55
-0.84
-0.82
Total Expenditure (Excl Depreciation)
4,276.14
3,625.50
3,019.59
2,216.88
1,796.09
1,429.81
Operating Profit (PBDIT) excl Other Income
231.8
154.9
225.6
108.69999999999999
123.4
83.4
Other Income
36.29
35.13
18.71
13.83
9.85
3.41
Operating Profit (PBDIT)
573.95
423.14
458.01
336.60
190.88
138.21
Interest
35.31
31.89
25.40
26.01
8.60
8.19
Exceptional Items
-17.20
0.03
0.00
-0.04
0.00
-0.00
Gross Profit (PBDT)
1,405.57
1,099.64
980.31
735.37
629.95
515.22
Depreciation
316.16
239.93
217.87
216.34
59.28
52.81
Profit Before Tax
205.29
151.35
214.74
94.22
123.00
77.21
Tax
53.21
33.83
54.48
24.48
34.14
23.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
137.70
114.67
160.78
69.73
88.92
51.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
137.70
114.67
160.78
69.73
88.92
51.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
14.56
3.01
-0.52
0.01
-0.06
1.40
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
152.26
117.68
160.26
69.73
88.86
53.35
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,005.29
1,943.53
947.28
784.80
714.83
536.21
Earnings per share (EPS)
0.34
0.29
0.4
0.17
0.22
0.13
Diluted Earnings per share
0.34
0.29
0.4
0.17
0.22
0.13
Operating Profit Margin (Excl OI)
4.91%
3.92%
6.82%
4.58%
6.34%
5.42%
Gross Profit Margin
11.57%
10.35%
13.33%
13.35%
9.5%
8.59%
PAT Margin
3.05%
3.03%
4.95%
3.0%
4.63%
3.43%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 19.24% vs 16.49% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 29.40% vs -26.58% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 38.58% vs -11.68% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 10.66% vs 25.59% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Anhui Huaren Health Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
4,507.94
0
4,507.94
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,507.94
0
4,507.94
Raw Material Cost
3,102.37
0
3,102.37
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
35.31
0
35.31
Selling and Distribution Expenses
1,145.58
0
1,145.58
Other Expenses
-0.71
0.00
-0.71
Total Expenditure (Excl Depreciation)
4,276.14
0
4,276.14
Operating Profit (PBDIT) excl Other Income
231.80
0.00
231.80
Other Income
36.29
0
36.29
Operating Profit (PBDIT)
573.95
0
573.95
Interest
35.31
0
35.31
Exceptional Items
-17.20
0
-17.20
Gross Profit (PBDT)
1,405.57
0
1,405.57
Depreciation
316.16
0
316.16
Profit Before Tax
205.29
0
205.29
Tax
53.21
0
53.21
Provisions and contingencies
0
0
0.00
Profit After Tax
137.70
0
137.70
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
137.70
0
137.70
Share in Profit of Associates
0
0
0.00
Minority Interest
14.56
0
14.56
Other related items
0.00
0.00
0.00
Consolidated Net Profit
152.26
0
152.26
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,005.29
0
2,005.29
Earnings per share (EPS)
0.34
0
0.34
Diluted Earnings per share
0.34
0
0.34
Operating Profit Margin (Excl OI)
4.91%
0%
0.00
4.91%
Gross Profit Margin
11.57%
0%
0.00
11.57%
PAT Margin
3.05%
0%
0.00
3.05%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 450.79 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 19.24% vs 16.49% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 15.23 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 29.40% vs -26.58% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 53.77 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 38.58% vs -11.68% in Dec 2023
Annual - Interest
Interest 3.53 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 10.66% vs 25.59% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.91%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






